InControl, EP MedSystems ink atrial defibrillation catheter agreement.
This article was originally published in The Gray Sheet
Executive Summary
INCONTROL/EP MEDSYSTEMS ATRIAL DEFIBRILLATION CATHETER AGREEMENT involves a supply/distribution exchange of rights to two developmental atrial defibrillation devices, the firms announced Aug. 15. Under the agreement, InControl obtains European marketing rights to EP Medsystems' Atrial Low Energy Reversion Therapy (ALERT) atrial defibrillation catheter; in return, EP Medsystems will manufacture InControl's temporary atrial defibrillation catheter, tentatively dubbed the TADcath.